Connecting Industries Worldwide

Chemicals and Pharmaceuticals

Croda International Plc, the speciality chemical manufacturing company, has announced that it has acquired Nautilus Biosciences Canada Inc, a technology-rich marine biotechnology company based in Charlottetown, Prince Edward Island, Canada.

Read more ...

Clariant, a world leader in speciality chemicals, has announced that it has signed two key agreements with SINOPEC, China's largest petroleum and chemical company.

Read more ...

Sebaceous glands help the skin stay moist and protect it against external influences such as harsh weather, pollution, and microbial assaults: The oily or waxy matter that these microscopic, exocrine glands secrete – called sebum – lubricates and softens the skin and hair.

Read more ...

Cornelius Group Plc, a European distributor and manufacturer of speciality chemicals, ingredients and raw materials for the performance chemicals, personal care, health and nutrition markets, has announced the appointment of a new Group Finance Director.

Read more ...

A team of researchers from Queen’s University Belfast, led by Professor Ryan Donnelly, Professor of Pharmaceutical Technology are developing a new type of skin patch (microarray patch) that administers drugs directly into the bloodstream through thousands of individual “microneedles” which are being tested as a possible answer to the antibiotic resistance crisis.

Read more ...

3M has developed a “Find My Adhesive” product selector tool to help make medical adhesive selection a simpler process. The product selector tool will be available to demo at CES 2018 in Las Vegas from 9th – 12th January in the 3M booth within the Health & Wellness Marketplace.

Read more ...

Novartis has announced Kisqali® received US Food and Drug Administration (FDA) Breakthrough Therapy designation for the initial endocrine-based treatment of pre- or perimenopausal women with hormone-receptor-positive, human epidermal growth factor receptor-2 negative (HR+/HER2-) advanced or metastatic breast cancer in combination with tamoxifen or an aromatase inhibitor.

Read more ...

W. R. Grace & Co. has recently signed an agreement to acquire the Polyolefin Catalysts business of Albemarle Corporation for $416 million. The transaction is expected to close in the first quarter of 2018, subject to regulatory approvals and other customary closing conditions.

Read more ...